CYMABAY THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 20 Debt SecuritiesIndenture • May 11th, 2017 • CymaBay Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 11th, 2017 Company Industry JurisdictionINDENTURE, dated as of [●], 20 , among CymaBay Therapeutics, Inc., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
CYMABAY THERAPEUTICS, INC. AND , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OFPreferred Stock Warrant Agreement • May 11th, 2017 • CymaBay Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 11th, 2017 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between CYMABAY THERAPEUTICS, INC., a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
CYMABAY THERAPEUTICS, INC. AND , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OFCommon Stock Warrant Agreement • May 11th, 2017 • CymaBay Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 11th, 2017 Company Industry JurisdictionTHIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between CYMABAY, INC., a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
CYMABAY THERAPEUTICS, INC. AND , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFWarrant Agreement • May 11th, 2017 • CymaBay Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 11th, 2017 Company Industry JurisdictionTHIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between CYMABAY THERAPEUTICS, INC, a Delaware corporation (the “Company”) and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
CYMABAY THERAPEUTICS, INC. Shares of Common Stock (par value $0.0001 per share) Capital on Demand™ Sales AgreementCapital on Demand Sales Agreement • May 11th, 2017 • CymaBay Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 11th, 2017 Company Industry JurisdictionCymaBay Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows: